BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10391237)

  • 21. Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease.
    Chen CH; Li W; Sultana R; You MH; Kondo A; Shahpasand K; Kim BM; Luo ML; Nechama M; Lin YM; Yao Y; Lee TH; Zhou XZ; Swomley AM; Butterfield DA; Zhang Y; Lu KP
    Neurobiol Dis; 2015 Apr; 76():13-23. PubMed ID: 25576397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.
    Blair LJ; Baker JD; Sabbagh JJ; Dickey CA
    J Neurochem; 2015 Apr; 133(1):1-13. PubMed ID: 25628064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pinning down cell division.
    Vogel G
    Science; 1997 Dec; 278(5345):1883-4. PubMed ID: 9417635
    [No Abstract]   [Full Text] [Related]  

  • 24. PINning down the c-Myc oncoprotein.
    Dominguez-Sola D; Dalla-Favera R
    Nat Cell Biol; 2004 Apr; 6(4):288-9. PubMed ID: 15057241
    [No Abstract]   [Full Text] [Related]  

  • 25. Pinning down cell signaling, cancer and Alzheimer's disease.
    Lu KP
    Trends Biochem Sci; 2004 Apr; 29(4):200-9. PubMed ID: 15082314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
    Takeda M; Kudo T; Taniguchi N; Nishimura T
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
    [No Abstract]   [Full Text] [Related]  

  • 27. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
    Mondragón-Rodríguez S; Perry G; Luna-Muñoz J; Acevedo-Aquino MC; Williams S
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):121-35. PubMed ID: 24033439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parasite biology: PINning down Theileria.
    Attar N
    Nat Rev Microbiol; 2015 Mar; 13(3):126-7. PubMed ID: 25659319
    [No Abstract]   [Full Text] [Related]  

  • 29. Tau phosphorylation and aggregation in Alzheimer's disease pathology.
    Avila J
    FEBS Lett; 2006 May; 580(12):2922-7. PubMed ID: 16529745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease.
    van Abel D; Abdulhamid O; Scheper W; van Dijk M; Oudejans CB
    Neurosci Lett; 2012 Oct; 528(2):104-9. PubMed ID: 22995177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent metabolic dysregulation in cancer and Alzheimer's disease.
    Harris RA; Tindale L; Cumming RC
    Biogerontology; 2014 Dec; 15(6):559-77. PubMed ID: 25305052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immuno-PCR-based quantification of multiple phosphorylated tau-epitopes linked to Alzheimer's disease.
    Singer D; Soininen H; Alafuzoff I; Hoffmann R
    Anal Bioanal Chem; 2009 Dec; 395(7):2263-7. PubMed ID: 19821112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inge Grundke-Iqbal, Ph.D. (1937–2012): the discoverer of the abnormal hyperphosphorylation of tau in Alzheimer’s disease.
    Alonso Adel C; ElAkkad E; Gong C; Liu F; Tanaka T; Kudo T; Tatebayashi Y; Pei J; Wang J; Khatoon S; Flory M; Ghetti B; Gozes I; Novak M; Novak M; Robakis NK; de Leon M; Iqbal M
    J Mol Neurosci; 2013 Feb; 49(2):430-5. PubMed ID: 24883456
    [No Abstract]   [Full Text] [Related]  

  • 35. Alzheimer's disease. The tangled tale of tau.
    Mandelkow E
    Nature; 1999 Dec; 402(6762):588-9. PubMed ID: 10604460
    [No Abstract]   [Full Text] [Related]  

  • 36. Tau protein in Alzheimer's disease.
    Goedert M; Jakes R; Spillantini MG; Crowther RA; Cohen P; Vanmechelen E; Probst A; Götz J; Bürki K
    Biochem Soc Trans; 1995 Feb; 23(1):80-5. PubMed ID: 7758799
    [No Abstract]   [Full Text] [Related]  

  • 37. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease.
    Preuss U; Mandelkow EM
    Eur J Cell Biol; 1998 Jul; 76(3):176-84. PubMed ID: 9716264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pin-ning down immune responses to RNA viruses.
    Goutagny N; Severa M; Fitzgerald KA
    Nat Immunol; 2006 Jun; 7(6):555-7. PubMed ID: 16715065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.